-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DqAIClh8A0M9vE9xzNxjKKw6j9+QilcuyU54P/gxpD70Ou4YZkpivnqt9VDz0WS6 vOa5sVOzkT88Aty0eS1uzA== 0001144204-08-062097.txt : 20081110 0001144204-08-062097.hdr.sgml : 20081110 20081107215010 ACCESSION NUMBER: 0001144204-08-062097 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081104 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20081110 DATE AS OF CHANGE: 20081107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21615 FILM NUMBER: 081173227 BUSINESS ADDRESS: STREET 1: 321 MANLEY STREET CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 BUSINESS PHONE: 5085801818 MAIL ADDRESS: STREET 1: 321 MANLEY STREET CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON BIOMEDICA INC DATE OF NAME CHANGE: 19960812 8-K 1 v131196_8k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 4, 2008

PRESSURE BIOSCIENCES, INC.
(Exact Name of Registrant as Specified in its Charter)

MASSACHUSETTS
  (State or Other Jurisdiction of Incorporation)
 
0-21615
 
04-2652826
(Commission File Number)
 
(IRS Employer Identification No.)
 
14 Norfolk Avenue, South Easton, MA
 
02375
(Address of Principal Executive Offices)
 
(Zip Code)
 
(508) 230-1828
(Registrant’s Telephone Number, Including Area Code)
 
 
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 
 
On November 4, 2008, Mr. Edward H. Myles informed the Company that he would be resigning from his position of Senior Vice President and Chief Financial Officer, to pursue other opportunities, effective November 18, 2008. After his effective resignation date, Mr. Myles will provide transitional consulting services to the Company, on an as needed basis.   
 
 
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
Dated: November 7, 2008
PRESSURE BIOSCIENCES, INC.
 
 
 
 
 
 
 
By:  
/s/ Edward H. Myles
 
Edward H. Myles,
Senior Vice President of Finance and
Chief Financial Officer
 
 
 
-3-
 
 -----END PRIVACY-ENHANCED MESSAGE-----